trending Market Intelligence /marketintelligence/en/news-insights/trending/l33u1-ockdxsl7cp7od88q2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Ziopharm Oncology nominates board member

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Ziopharm Oncology nominates board member

Ziopharm Oncology Inc. named Scott Braunstein for election to its board at the company's annual meeting of stockholders on Sept. 18.

Braunstein has been a partner at Aisling Capital Management LP since August 2015. He has also served as COO of Pacira Pharmaceuticals Inc.